tert-Butyl 1,5-naphthyridin-3-ylcarbamate

Catalog No. :
ACANCJ985
CAS No. :
959617-73-3
Molecular Formula :
C13H15N3O2
Molecular Weight :
245.28

IUPAC Name:tert-butyl (1,5-naphthyridin-3-yl)carbamate

tert-Butyl 1,5-naphthyridin-3-ylcarbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$186.00Login to see priceInquiryInquiry
250mg97%$294.00Login to see priceInquiryInquiry
1g97%$738.00Login to see priceInquiryInquiry
5g97%$2221.00Login to see priceInquiryInquiry
10g97%$3701.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 1,5-naphthyridin-3-ylcarbamate
IUPAC Nametert-butyl (1,5-naphthyridin-3-yl)carbamate
MDL No.MFCD24467536
Molecular FormulaC13H15N3O2
Molecular Weight245.28
SMILESO=C(OC(C)(C)C)NC1=CC2=NC=CC=C2N=C1
InChI KeyGSTMUJGINQFVNK-UHFFFAOYSA-N
Synonymtert-butyl 1,5-naphthyridin-3-ylcarbaMate;Carbamic acid, N-1,5-naphthyridin-3-yl-, 1,1-dimethylethyl ester
CAS No.959617-73-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACANCJ985 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLYSK685 route compound structure diagram
    ACLYSK68514756-77-5 In Stock
  4. Then
  5. ACANCJ985 route product structure diagram
    ACANCJ985959617-73-3
Inquiry

2. ACANCJ985 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIWKR198 route compound structure diagram
    ACIWKR19817965-71-8 In Stock
  2. Plus
  3. ACEHQO530 route compound structure diagram
    ACEHQO5304248-19-5 In Stock
  4. Then
  5. ACANCJ985 route product structure diagram
    ACANCJ985959617-73-3
Inquiry

Comments (0)